[Treatment of hypertriglyceridemia with omega-3 fatty acids].

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Omega-3 fatty acids such as eicosapentaenoic acid(EPA) and docosahexaenoic acid(DHA) have important biologic functions, including effects on membranes, eicosanoid metabolism, and gene transcription. Studies indicate that the use of EPA and DHA lowered triglyceride levels, which is accomplished by decreasing the production of hepatic triglycerides and increasing the clearance of plasma triglycerides. Recent clinical studies showed that intake of omega-3 fatty acids reduced cardiovascular events. In addition, combination therapy with omega-3 fatty acids and a statin is a safe and effective way to improve lipid levels and cardiovascular prognosis beyond the benefits provided by statin therapy alone. Our focus is to review the potential mechanisms by which these fatty acids reduce cardiovascular disease risk.

Original languageEnglish
Pages (from-to)1650-1654
Number of pages5
JournalNihon rinsho. Japanese journal of clinical medicine
Volume71
Issue number9
Publication statusPublished - Sep 2013

Fingerprint

Hypertriglyceridemia
Omega-3 Fatty Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Triglycerides
Eicosapentaenoic Acid
Docosahexaenoic Acids
Eicosanoids
Cardiovascular Diseases
Fatty Acids
Lipids
Membranes
Liver
Therapeutics
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Treatment of hypertriglyceridemia with omega-3 fatty acids]. / Miyoshi, Toru; Itoh, Hiroshi.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 71, No. 9, 09.2013, p. 1650-1654.

Research output: Contribution to journalArticle

@article{8e2192e5a27749f9a3009015a172b8d5,
title = "[Treatment of hypertriglyceridemia with omega-3 fatty acids].",
abstract = "Omega-3 fatty acids such as eicosapentaenoic acid(EPA) and docosahexaenoic acid(DHA) have important biologic functions, including effects on membranes, eicosanoid metabolism, and gene transcription. Studies indicate that the use of EPA and DHA lowered triglyceride levels, which is accomplished by decreasing the production of hepatic triglycerides and increasing the clearance of plasma triglycerides. Recent clinical studies showed that intake of omega-3 fatty acids reduced cardiovascular events. In addition, combination therapy with omega-3 fatty acids and a statin is a safe and effective way to improve lipid levels and cardiovascular prognosis beyond the benefits provided by statin therapy alone. Our focus is to review the potential mechanisms by which these fatty acids reduce cardiovascular disease risk.",
author = "Toru Miyoshi and Hiroshi Itoh",
year = "2013",
month = "9",
language = "English",
volume = "71",
pages = "1650--1654",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "9",

}

TY - JOUR

T1 - [Treatment of hypertriglyceridemia with omega-3 fatty acids].

AU - Miyoshi, Toru

AU - Itoh, Hiroshi

PY - 2013/9

Y1 - 2013/9

N2 - Omega-3 fatty acids such as eicosapentaenoic acid(EPA) and docosahexaenoic acid(DHA) have important biologic functions, including effects on membranes, eicosanoid metabolism, and gene transcription. Studies indicate that the use of EPA and DHA lowered triglyceride levels, which is accomplished by decreasing the production of hepatic triglycerides and increasing the clearance of plasma triglycerides. Recent clinical studies showed that intake of omega-3 fatty acids reduced cardiovascular events. In addition, combination therapy with omega-3 fatty acids and a statin is a safe and effective way to improve lipid levels and cardiovascular prognosis beyond the benefits provided by statin therapy alone. Our focus is to review the potential mechanisms by which these fatty acids reduce cardiovascular disease risk.

AB - Omega-3 fatty acids such as eicosapentaenoic acid(EPA) and docosahexaenoic acid(DHA) have important biologic functions, including effects on membranes, eicosanoid metabolism, and gene transcription. Studies indicate that the use of EPA and DHA lowered triglyceride levels, which is accomplished by decreasing the production of hepatic triglycerides and increasing the clearance of plasma triglycerides. Recent clinical studies showed that intake of omega-3 fatty acids reduced cardiovascular events. In addition, combination therapy with omega-3 fatty acids and a statin is a safe and effective way to improve lipid levels and cardiovascular prognosis beyond the benefits provided by statin therapy alone. Our focus is to review the potential mechanisms by which these fatty acids reduce cardiovascular disease risk.

UR - http://www.scopus.com/inward/record.url?scp=84892187573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892187573&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 1650

EP - 1654

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 9

ER -